Christopher Rovaldi - Insider Trading & Ownership

Entity
Individual
Location
C/O Acceleron Pharma Inc., 128 Sidney St., Cambridge, MA
All Insider Reports
All Insider Reports

Ownership of Christopher Rovaldi

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KROS Keros Therapeutics, Inc. Chief Operating Officer Feb 13, 2024

Insider Transactions Reported by Christopher Rovaldi:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.